As a Free StocksGuide user, you can view scores for all 7,024 stocks worldwide.
7 Analysts have issued a Protagenic Therapeutics Inc forecast:
7 Analysts have issued a Protagenic Therapeutics Inc forecast:
| Jun '25 |
+/-
%
|
||
| Revenue | - - |
-
|
|
| Gross Profit | - - |
-
|
|
| EBITDA | -5.96 -5.96 |
1%
1%
|
|
| EBIT (Operating Income) EBIT | -6.01 -6.01 |
1%
1%
|
|
| Net Profit | -8.69 -8.69 |
36%
36%
|
|
In millions USD.
If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.
Protagenic Therapeutics, Inc. is a biotechnology company, which engages in the discovery and development of therapeutics to treat stress-related neuropsychiatric and mood disorders. It offers the PT00114 peptide-based formulations. The company was founded by Garo H. Armen, David A. Lovejoy, and Hartoun Hartounian on February 3, 1994 and is headquartered in New York, NY.
| Head office | United States |
| Employees | 2 |
| Founded | 1994 |
| Website | protagenic.com |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.


